Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 181 to 186 of 186 entries
Sorted by: Best Match Show Resources per page
Admission Urinary and Serum Metabolites Predict Renal Outcomes in Hospitalized Patients With Cirrhosis.

Hepatology (Baltimore, Md.)

Bajaj JS, Garcia-Tsao G, Reddy KR, O'Leary JG, Vargas HE, Lai JC, Kamath PS, Tandon P, Subramanian RM, Thuluvath P, Fagan A, Sehrawat T, de la Rosa Rodriguez R, Thacker LR, Wong F.
PMID: 34002868
Hepatology. 2021 Nov;74(5):2699-2713. doi: 10.1002/hep.31907. Epub 2021 Jul 08.

BACKGROUND AND AIMS: Acute kidney injury (AKI) has a poor prognosis in cirrhosis. Given the variability of creatinine, the prediction of AKI and dialysis by other markers is needed. The aim of this study is to determine the role...

Cite
Bajaj JS, Garcia-Tsao G, Reddy KR, et al. Admission Urinary and Serum Metabolites Predict Renal Outcomes in Hospitalized Patients With Cirrhosis. Hepatology. 2021;74(5):2699-2713doi: 10.1002/hep.31907.
Bajaj, J. S., Garcia-Tsao, G., Reddy, K. R., O'Leary, J. G., Vargas, H. E., Lai, J. C., Kamath, P. S., Tandon, P., Subramanian, R. M., Thuluvath, P., Fagan, A., Sehrawat, T., de la Rosa Rodriguez, R., Thacker, L. R., & Wong, F. (2021). Admission Urinary and Serum Metabolites Predict Renal Outcomes in Hospitalized Patients With Cirrhosis. Hepatology (Baltimore, Md.), 74(5), 2699-2713. https://doi.org/10.1002/hep.31907
Bajaj, Jasmohan S, et al. "Admission Urinary and Serum Metabolites Predict Renal Outcomes in Hospitalized Patients With Cirrhosis." Hepatology (Baltimore, Md.) vol. 74,5 (2021): 2699-2713. doi: https://doi.org/10.1002/hep.31907
Bajaj JS, Garcia-Tsao G, Reddy KR, O'Leary JG, Vargas HE, Lai JC, Kamath PS, Tandon P, Subramanian RM, Thuluvath P, Fagan A, Sehrawat T, de la Rosa Rodriguez R, Thacker LR, Wong F. Admission Urinary and Serum Metabolites Predict Renal Outcomes in Hospitalized Patients With Cirrhosis. Hepatology. 2021 Nov;74(5):2699-2713. doi: 10.1002/hep.31907. Epub 2021 Jul 08. PMID: 34002868.
Copy Download .nbib Format: NLM
Network dysfunction in cognitively normal APOE ε4 carriers is related to subclinical tau.

Alzheimer's & dementia : the journal of the Alzheimer's Association

Butt OH, Meeker KL, Wisch JK, Schindler SE, Fagan AM, Benzinger TLS, Cruchaga C, Holtzman DM, Morris JC, Ances BM.
PMID: 34002449
Alzheimers Dement. 2021 May 18; doi: 10.1002/alz.12375. Epub 2021 May 18.

INTRODUCTION: Apolipoprotein E (APOE) ε4 allele status is associated with amyloid and tau-related pathological changes related to Alzheimer's disease (AD). However, it is unknown whether brain network changes are related to amyloid beta (Aβ) and/or tau-related pathology in cognitively...

Cite
Butt OH, Meeker KL, Wisch JK, et al. Network dysfunction in cognitively normal APOE ε4 carriers is related to subclinical tau. Alzheimers Dement. 2021;doi: 10.1002/alz.12375.
Butt, O. H., Meeker, K. L., Wisch, J. K., Schindler, S. E., Fagan, A. M., Benzinger, T. L. S., Cruchaga, C., Holtzman, D. M., Morris, J. C., & Ances, B. M. (2021). Network dysfunction in cognitively normal APOE ε4 carriers is related to subclinical tau. Alzheimer's & dementia : the journal of the Alzheimer's Association, . https://doi.org/10.1002/alz.12375
Butt, Omar H, et al. "Network dysfunction in cognitively normal APOE ε4 carriers is related to subclinical tau." Alzheimer's & dementia : the journal of the Alzheimer's Association vol. (2021). doi: https://doi.org/10.1002/alz.12375
Butt OH, Meeker KL, Wisch JK, Schindler SE, Fagan AM, Benzinger TLS, Cruchaga C, Holtzman DM, Morris JC, Ances BM. Network dysfunction in cognitively normal APOE ε4 carriers is related to subclinical tau. Alzheimers Dement. 2021 May 18; doi: 10.1002/alz.12375. Epub 2021 May 18. PMID: 34002449.
Copy Download .nbib Format: NLM
Stool microbiota are superior to saliva in distinguishing cirrhosis and hepatic encephalopathy using machine learning.

Journal of hepatology

Saboo K, Petrakov NV, Shamsaddini A, Fagan A, Gavis EA, Sikaroodi M, McGeorge S, Gillevet PM, Iyer RK, Bajaj JS.
PMID: 34793867
J Hepatol. 2021 Nov 15; doi: 10.1016/j.jhep.2021.11.011. Epub 2021 Nov 15.

BACKGROUND AND AIMS: Salivary and stool microbiota are altered in cirrhosis. Since stool is logistically difficult to collect compared to saliva, it is important to determine their relative capability in differentiating groups. We aimed to determine the ability of...

Cite
Saboo K, Petrakov NV, Shamsaddini A, et al. Stool microbiota are superior to saliva in distinguishing cirrhosis and hepatic encephalopathy using machine learning. J Hepatol. 2021;doi: 10.1016/j.jhep.2021.11.011.
Saboo, K., Petrakov, N. V., Shamsaddini, A., Fagan, A., Gavis, E. A., Sikaroodi, M., McGeorge, S., Gillevet, P. M., Iyer, R. K., & Bajaj, J. S. (2021). Stool microbiota are superior to saliva in distinguishing cirrhosis and hepatic encephalopathy using machine learning. Journal of hepatology, . https://doi.org/10.1016/j.jhep.2021.11.011
Saboo, Krishnakant, et al. "Stool microbiota are superior to saliva in distinguishing cirrhosis and hepatic encephalopathy using machine learning." Journal of hepatology vol. (2021). doi: https://doi.org/10.1016/j.jhep.2021.11.011
Saboo K, Petrakov NV, Shamsaddini A, Fagan A, Gavis EA, Sikaroodi M, McGeorge S, Gillevet PM, Iyer RK, Bajaj JS. Stool microbiota are superior to saliva in distinguishing cirrhosis and hepatic encephalopathy using machine learning. J Hepatol. 2021 Nov 15; doi: 10.1016/j.jhep.2021.11.011. Epub 2021 Nov 15. PMID: 34793867.
Copy Download .nbib Format: NLM
Evaluation of the Recovery Engagement and Coordination for Health-Veterans Enhanced Treatment Suicide Risk Modeling Clinical Program in the Veterans Health Administration.

JAMA network open

McCarthy JF, Cooper SA, Dent KR, Eagan AE, Matarazzo BB, Hannemann CM, Reger MA, Landes SJ, Trafton JA, Schoenbaum M, Katz IR.
PMID: 34661661
JAMA Netw Open. 2021 Oct 01;4(10):e2129900. doi: 10.1001/jamanetworkopen.2021.29900.

IMPORTANCE: The Veterans Health Administration (VHA) implemented a national clinical program using a suicide risk prediction algorithm, Recovery Engagement and Coordination for Health-Veterans Enhanced Treatment (REACH VET), in which clinicians facilitate care enhancements for individuals identified in local top...

Cite
McCarthy JF, Cooper SA, Dent KR, et al. Evaluation of the Recovery Engagement and Coordination for Health-Veterans Enhanced Treatment Suicide Risk Modeling Clinical Program in the Veterans Health Administration. JAMA Netw Open. 2021;4(10):e2129900doi: 10.1001/jamanetworkopen.2021.29900.
McCarthy, J. F., Cooper, S. A., Dent, K. R., Eagan, A. E., Matarazzo, B. B., Hannemann, C. M., Reger, M. A., Landes, S. J., Trafton, J. A., Schoenbaum, M., & Katz, I. R. (2021). Evaluation of the Recovery Engagement and Coordination for Health-Veterans Enhanced Treatment Suicide Risk Modeling Clinical Program in the Veterans Health Administration. JAMA network open, 4(10), e2129900. https://doi.org/10.1001/jamanetworkopen.2021.29900
McCarthy, John F, et al. "Evaluation of the Recovery Engagement and Coordination for Health-Veterans Enhanced Treatment Suicide Risk Modeling Clinical Program in the Veterans Health Administration." JAMA network open vol. 4,10 (2021): e2129900. doi: https://doi.org/10.1001/jamanetworkopen.2021.29900
McCarthy JF, Cooper SA, Dent KR, Eagan AE, Matarazzo BB, Hannemann CM, Reger MA, Landes SJ, Trafton JA, Schoenbaum M, Katz IR. Evaluation of the Recovery Engagement and Coordination for Health-Veterans Enhanced Treatment Suicide Risk Modeling Clinical Program in the Veterans Health Administration. JAMA Netw Open. 2021 Oct 01;4(10):e2129900. doi: 10.1001/jamanetworkopen.2021.29900. PMID: 34661661; PMCID: PMC8524305.
Copy Download .nbib Format: NLM
Effect of fat reformulated dairy food consumption on postprandial flow-mediated dilatation and cardiometabolic risk biomarkers compared with conventional dairy: a randomized, controlled trial.

The American journal of clinical nutrition

Markey O, Vasilopoulou D, Kliem KE, Fagan CC, Grandison AS, Sutton R, Humphries DJ, Todd S, Jackson KG, Givens DI, Lovegrove JA.
PMID: 35020795
Am J Clin Nutr. 2022 Jan 10; doi: 10.1093/ajcn/nqab428. Epub 2022 Jan 10.

BACKGROUND: Longer-term consumption of saturated fatty acid (SFA)-reduced, monounsaturated fatty acid (MUFA)-enriched dairy products have been reported to improve fasting flow-mediated vasodilation (FMD). Yet, their impact on endothelial function in the postprandial state warrants investigation.OBJECTIVES: To compare the impact...

Cite
Markey O, Vasilopoulou D, Kliem KE, et al. Effect of fat reformulated dairy food consumption on postprandial flow-mediated dilatation and cardiometabolic risk biomarkers compared with conventional dairy: a randomized, controlled trial. Am J Clin Nutr. 2022;doi: 10.1093/ajcn/nqab428.
Markey, O., Vasilopoulou, D., Kliem, K. E., Fagan, C. C., Grandison, A. S., Sutton, R., Humphries, D. J., Todd, S., Jackson, K. G., Givens, D. I., & Lovegrove, J. A. (2022). Effect of fat reformulated dairy food consumption on postprandial flow-mediated dilatation and cardiometabolic risk biomarkers compared with conventional dairy: a randomized, controlled trial. The American journal of clinical nutrition, . https://doi.org/10.1093/ajcn/nqab428
Markey, Oonagh, et al. "Effect of fat reformulated dairy food consumption on postprandial flow-mediated dilatation and cardiometabolic risk biomarkers compared with conventional dairy: a randomized, controlled trial." The American journal of clinical nutrition vol. (2022). doi: https://doi.org/10.1093/ajcn/nqab428
Markey O, Vasilopoulou D, Kliem KE, Fagan CC, Grandison AS, Sutton R, Humphries DJ, Todd S, Jackson KG, Givens DI, Lovegrove JA. Effect of fat reformulated dairy food consumption on postprandial flow-mediated dilatation and cardiometabolic risk biomarkers compared with conventional dairy: a randomized, controlled trial. Am J Clin Nutr. 2022 Jan 10; doi: 10.1093/ajcn/nqab428. Epub 2022 Jan 10. PMID: 35020795.
Copy Download .nbib Format: NLM
The Longitudinal Early-onset Alzheimer's Disease Study (LEADS): Framework and methodology.

Alzheimer's & dementia : the journal of the Alzheimer's Association

Apostolova LG, Aisen P, Eloyan A, Fagan A, Fargo KN, Foroud T, Gatsonis C, Grinberg LT, Jack CR, Kramer J, Koeppe R, Kukull WA, Murray ME, Nudelman K, Rumbaugh M, Toga A, Vemuri P, Trullinger A, Iaccarino L, Day GS, Graff-Radford NR, Honig LS, Jones DT, Masdeu J, Mendez M, Musiek E, Onyike CU, Rogalski E, Salloway S, Wolk DA, Wingo TS, Carrillo MC, Dickerson BC, Rabinovici GD.
PMID: 34018654
Alzheimers Dement. 2021 Dec;17(12):2043-2055. doi: 10.1002/alz.12350. Epub 2021 May 21.

Patients with early-onset Alzheimer's disease (EOAD) are commonly excluded from large-scale observational and therapeutic studies due to their young age, atypical presentation, or absence of pathogenic mutations. The goals of the Longitudinal EOAD Study (LEADS) are to (1) define...

Cite
Apostolova LG, Aisen P, Eloyan A, et al. The Longitudinal Early-onset Alzheimer's Disease Study (LEADS): Framework and methodology. Alzheimers Dement. 2021;17(12):2043-2055doi: 10.1002/alz.12350.
Apostolova, L. G., Aisen, P., Eloyan, A., Fagan, A., Fargo, K. N., Foroud, T., Gatsonis, C., Grinberg, L. T., Jack, C. R., Kramer, J., Koeppe, R., Kukull, W. A., Murray, M. E., Nudelman, K., Rumbaugh, M., Toga, A., Vemuri, P., Trullinger, A., Iaccarino, L., Day, G. S., Graff-Radford, N. R., Honig, L. S., Jones, D. T., Masdeu, J., Mendez, M., Musiek, E., Onyike, C. U., Rogalski, E., Salloway, S., Wolk, D. A., Wingo, T. S., Carrillo, M. C., Dickerson, B. C., Rabinovici, G. D. (2021). The Longitudinal Early-onset Alzheimer's Disease Study (LEADS): Framework and methodology. Alzheimer's & dementia : the journal of the Alzheimer's Association, 17(12), 2043-2055. https://doi.org/10.1002/alz.12350
Apostolova, Liana G, et al. "The Longitudinal Early-onset Alzheimer's Disease Study (LEADS): Framework and methodology." Alzheimer's & dementia : the journal of the Alzheimer's Association vol. 17,12 (2021): 2043-2055. doi: https://doi.org/10.1002/alz.12350
Apostolova LG, Aisen P, Eloyan A, Fagan A, Fargo KN, Foroud T, Gatsonis C, Grinberg LT, Jack CR, Kramer J, Koeppe R, Kukull WA, Murray ME, Nudelman K, Rumbaugh M, Toga A, Vemuri P, Trullinger A, Iaccarino L, Day GS, Graff-Radford NR, Honig LS, Jones DT, Masdeu J, Mendez M, Musiek E, Onyike CU, Rogalski E, Salloway S, Wolk DA, Wingo TS, Carrillo MC, Dickerson BC, Rabinovici GD. The Longitudinal Early-onset Alzheimer's Disease Study (LEADS): Framework and methodology. Alzheimers Dement. 2021 Dec;17(12):2043-2055. doi: 10.1002/alz.12350. Epub 2021 May 21. PMID: 34018654.
Copy Download .nbib Format: NLM
Showing 181 to 186 of 186 entries